Skip to main content

Table 2 Vγ2 clonotype frequencies in IL-2 treated cultures.

From: Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

Clonotypes

Ex Vivo

IPP

IL2

DONOR: ND001

2008

2008

2008

CALW         SR         ELG

34

21

25

CALWE         A         ELG

28

14

34

CALWE         RK   QELG

6

9

<3

CALWEV      RK         LG

<3

4

<3

CALWEV               QELG

<3

3

<3

CALWE         T      QELG

<3

21

<3

CALWE         TE   QELG

<3

10

<3

N

158

239

268

DONOR: ND006

   

CALWEV               QELG

13

13

<3

CALWE         AK      ELG

9

10

<3

CALWE         A      QELG

6

12

<3

CALWEV      R         ELG

4

4

<3

N

206

287

172

DONOR: ND019

   

CALWEV      D         ELG

36

23

<3

CALWE      PQ      QELG

5

7

<3

CALWEV               QELG

8

5

6

CALWEV   R            ELG

<3

8

9

CALWE      A         QELG

9

7

18

CALWE      IE      QELG

<3

5

<3

N

256

246

242

  1. Vγ2 chains from donor PBMC, IPP-stimulated cell lines, and IL-2 only treated cells were sequenced. Individual Vγ2 clonotypes frequencies for stable clonotypes were calculated as a proportion of total sequences obtained from each donor sample. Any sequences present at a frequency below 3% are under the limits of detection for this assay. The total numbers of sequences analyzed for each sample are listed.